Joanna Wiensch
Stock Analyst at Citigroup
(2.56)
# 2,173
Out of 5,127 analysts
30
Total ratings
71.43%
Success rate
8.04%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Downgrades: Neutral | $217 → $185 | $205.18 | -9.84% | 7 | May 22, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $126.18 | +0.65% | 8 | Aug 22, 2024 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $68.43 | +31.89% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $83.13 | -4.37% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Technologies | Initiates: Buy | $120 | $189.25 | -36.59% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $315.54 | -36.62% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $114.15 | -64.96% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $94.08 | +78.57% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $80.62 | -21.86% | 1 | Mar 5, 2020 | |
| SYK Stryker | Initiates: Buy | $235 | $367.21 | -36.00% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $292.89 | -24.89% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $84.58 | -0.69% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $20.69 | +354.33% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $205.75 | -20.78% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $98.69 | +25.65% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
May 22, 2025
Downgrades: Neutral
Price Target: $217 → $185
Current: $205.18
Upside: -9.84%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $126.18
Upside: +0.65%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $68.43
Upside: +31.89%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $83.13
Upside: -4.37%
iRhythm Technologies
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $189.25
Upside: -36.59%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $315.54
Upside: -36.62%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $114.15
Upside: -64.96%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $94.08
Upside: +78.57%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $80.62
Upside: -21.86%
Stryker
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $367.21
Upside: -36.00%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $292.89
Upside: -24.89%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $84.58
Upside: -0.69%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $20.69
Upside: +354.33%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $205.75
Upside: -20.78%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $98.69
Upside: +25.65%